Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion type Assertion NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_head.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion description "[In contrast, for the 67 patients with inflammatory breast carcinoma, the most aggressive type of breast carcinoma, the c-erbB2 amplification detected in 24 (36%) specimens was not found to be associated with a higher risk of death, suggesting that the c-erbB2 gene plays a different role in the progression of these 2 types of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_provenance.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion evidence source_evidence_literature NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_provenance.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion SIO_000772 7927865 NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_provenance.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion wasDerivedFrom befree-2016 NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_provenance.
- NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_assertion wasGeneratedBy ECO_0000203 NP1327277.RAYeGcm1ZzNnCWnpdLsiwUjZAABlBBTpiOY3D0-74kNHc130_provenance.